Owens Community College has launched a new cardiac sonography program aimed at addressing a growing shortage of trained heart ...

ForaCare’s integration with athenahealth’s Marketplace streamlines provider access to scalable RPM, CCM, and RTM ...

Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.

Pulsed field ablation allows us to treat AFib in a way that is minimally invasive, efficient and designed to enhance ...

Achieving remission from prediabetes dramatically reduces the risk of heart disease and other major cardiovascular events.

Issued on behalf of Avaí Bio, Inc.Companies mentioned in this article: Avaí Bio (OTCQB: AVAI), FibroBiologics (NASDAQ: FBLG), Fate Therapeutics ...

Three presentations at ACC reinforce Heartflow’s AI-powered technology predicts MACE, drives superior lipid outcomes and results in ...

CRISPR Therapeutics (NASDAQ:CRSP) used a fireside chat at TD Cowen’s 46th Annual Healthcare Conference to outline how the company is trying to broaden its identity beyond its first commercial product, ...

AAA Biotech’s Validated Antibodies, Recombinant Proteins, and ELISA Kits Power Breakthrough Research Across Drug ...

Wayne General is integrating Eko SENSORA digital auscultation and ECG analytics at the point of care to increase sensitivity for structural heart disease and arrhythmias during routine exams. Rural ...

Allelica, a leader in genomic risk assessment for common diseases, announced today that polygenic risk scores (PRS) have been recognized as a risk-enhancing factor in the 2026 American College of ...

The U.S. peptide therapeutics market had an estimated valuation of $21 billion in 2025, and is projected to grow to nearly $35 billion by 2035 (1). Injectable peptides are currently the most dominant ...